Search Results for agency_names:"Health and Human Services Department"

The National Institute of Allergy and Infectious Diseases (NIAID) will hold a closed meeting from January 14 to 16, 2025, to review contract proposals for developing immunologic analysis reagents for specific animal models. The meeting will remain private to protect sensitive trade secrets and personal information. It will be conducted via video at the NIAID headquarters in Rockville, Maryland. Dr. Poonam Tewary, the Scientific Review Officer, will oversee the evaluation process.

The National Institute of Neurological Disorders and Stroke has announced a closed meeting of a special emphasis panel. This meeting, scheduled for February 11, 2021, will review and evaluate grant applications related to human biospecimen and data repository projects. It will take place virtually at the National Institutes of Health's Neuroscience Center in Rockville, Maryland. The meeting will remain closed to the public to protect confidential information and personal privacy associated with the grant discussions.

The Centers for Disease Control and Prevention (CDC) is inviting public comments on the ongoing research data collection process by the National Center for Health Statistics (NCHS). This involves feedback on the Research Data Center's (RDC) proposal for granting access to confidential data, necessary for researchers to conduct their projects. The notice is part of an effort under the Paperwork Reduction Act to reduce public burdens and enhance data utility. Comments must be submitted by February 3, 2025, and should follow submission guidelines through the federal eRulemaking portal or by mail.

The National Institutes of Health announced a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel to review grant applications. The meeting is scheduled for April 15, 2025, from 11:00 a.m. to 1:00 p.m. and will be conducted virtually. The meeting will be closed to the public because discussions may involve confidential information such as trade secrets and personal details that require privacy protection.

The National Heart, Lung, and Blood Institute has canceled a meeting that was originally scheduled for April 23, 2025, at the National Institutes of Health in Bethesda, Maryland. This meeting, which was a contract review session for the National Gene Vector Biorepository, was canceled because the related funding was not secured. The cancellation was announced in a notice published in the Federal Register.

The National Institutes of Health announced a change to the Bacterial-Host Interactions Study Section meeting schedule. Originally set to begin at 8:30 a.m. on April 10, 2025, the meeting will now start at 9:00 a.m. The meeting will take place as planned between April 10 and April 11, 2025, at the NIH in Bethesda, MD, and it will be closed to the public. This update was published in the Federal Register on March 31, 2025.

The Centers for Disease Control and Prevention (CDC) has submitted a request for approval from the Office of Management and Budget (OMB) to conduct an information collection project focused on law enforcement training. This project aims to address the health and safety risks associated with shift work and long work hours by developing a training program for officers. The pilot study will involve 60 law enforcement officers, using surveys and wearable devices to track sleep and evaluate the effectiveness of the training. The goal is to improve the quality of work schedules and personal strategies to help officers manage the demands of their job. Public comments on this project are encouraged within 30 days of this notice.

The Health and Human Services Department has released a final rule aimed at enhancing access to electronic health information while addressing concerns about privacy and legal implications for patients and providers, especially concerning reproductive health care. This rule refines existing information blocking exceptions and introduces a new "Protecting Care Access Exception," allowing health care providers to withhold certain sensitive information to avoid potential legal risks related to seeking, obtaining, or providing lawful reproductive health care. The rule aims to protect patient trust and ensure that health care providers continue to use digital records, thus avoiding a return to paper methods that could hinder patient care and health IT advancements. Additionally, it emphasizes that if any part of this rule is legally challenged, the remaining provisions will still stand.

The Food and Drug Administration (FDA) is organizing a public workshop called "Optimizing Pregnancy Registries" on March 27-28, 2025, both in-person at the FDA White Oak Campus in Silver Spring, MD, and online. The aim of the workshop is to address the challenges in designing pregnancy registries and discuss innovative approaches to enhance their effectiveness in assessing the safety of drugs and biological products during pregnancy. The event is in collaboration with the University of Maryland's Center of Excellence in Regulatory Science and Innovation program. Participants from academia, industry, healthcare, and patient communities will explore strategies to improve these registries.

The Food and Drug Administration (FDA) has issued a correction notice regarding a previously published document in the Federal Register on January 7, 2025. The original document announced the availability of final guidance for industry titled "Action Levels for Lead in Processed Food Intended for Babies and Young Children" but contained an error in the Background section. The correction clarifies that the parenthetical citation should refer to "88 FR 4797" instead of the incorrect information. This correction ensures accuracy in the FDA's guidance documentation.